Interact

CMO Speak

Dr. Frederick Greene, our Chief Medical Officer has leveraged his extensive surgical experience and his ongoing editorial experiences with the AJCC and CoC to drive several initiatives for CRStar - including the industry's first podcast focused on Cancer Registry.

Clinical Corner

Clinical Corner - September 2023

September 12, 2023
One of the interesting themes in cancer treatment over the last few years has been “de-escalation” of traditional treatment strategies; in other words, eliminating certain types of treatment that may not be necessary to achieve a good outcome. An example of this concept has been highlighted in the recent PROSPECT trial for rectal cancer. Pelvic […]
Read More

Clinical Corner - August 2023

August 23, 2023
Currently there is an explosion of data that associates body weight to a variety of cancers. Although clinicians and epidemiologists have used the Body Mass Index (BMI = weight in kilograms/height in meters2) as an indicator of ideal weight and obesity, recent discussions support that BMI is insufficient to fully indicate levels of obesity. What […]
Read More

Clinical Corner - July 2023

July 11, 2023
The most common adult primary intracranial neoplasms are meningiomas. The age-adjusted incidence of meningiomas reported in the United States is 12 per 100,000 women per year and it continues to increase, according to the Central Brain Tumor Registry of the United States. Since many of our cancer registries collect meningiomas and include them as a […]
Read More

Clinical Corner - June 2023

June 15, 2023
As I write this “Clinical Corner” one day prior to the 79th anniversary of D-Day, it is appropriate to remember not only the ultimate sacrifices of our military personnel in all prior conflicts, but to highlight also the cancer-related associations reported in those who have served. One such recent report underscores some of these associations. […]
Read More

Clinical Corner - May 2023

May 16, 2023
A prospective study reported in The Lancet Oncology, reported that endoscopic surveillance may be an alternative to prophylactic total gastrectomy in patients at risk for hereditary diffuse gastric cancer due to germline CDH1 pathogenic variants. In the study, 270 patients with germline CDH1 variants underwent endoscopic screening and surveillance as part of a natural history […]
Read More
chevron-down